Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Medicine and Science in Sports and Exercise|February 2, 2023
Efficacy and Feasibility of Presurgical Exercise in Bladder Cancer Patients Scheduled for Open Radical CystectomyDennis R Taaffe, Steve P McCombie, Daniel A Galvão, et al.BMC Cancer|March 20, 2014
Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapiesPrue Cormie, Suzanne K Chambers, Robert U Newton, et al.BMJ Open|June 6, 2022
Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial)Daniel A Galvão, Dennis R Taaffe, Dickon Hayne, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcomeNigel Spry, Jennifer Harvey, Craig Macleod, et al.Nature Reviews. Urology|March 9, 2016
Enhancing active surveillance of prostate cancer: the potential of exercise medicineDaniel A Galvão, Dennis R Taaffe, Nigel Spry, et al.JAMA Network Open|March 12, 2025
Exercise and Psychosexual Education to Improve Sexual Function in Men With Prostate Cancer: A Randomized Clinical TrialDaniel A Galvão, Robert U Newton, Dennis R Taaffe, et al.Medicine and Science in Sports and Exercise|October 17, 2017
Exercise Preserves Physical Function in Prostate Cancer Patients with Bone MetastasesDaniel A Galvão, Dennis R Taaffe, Nigel Spry, et al.Radiation Oncology (London, England)|August 31, 2018
International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV studyGeorgia K B Halkett, Charles Adam Wigley, Samar M Aoun, et al.Medicine and Science in Sports and Exercise|August 23, 2019
Reporting of Resistance Training Dose, Adherence, and Tolerance in Exercise OncologyCiaran M Fairman, Tormod S Nilsen, Robert U Newton, et al.The Lancet. Oncology|May 9, 2016
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialGillian M Duchesne, Henry H Woo, Julie K Bassett, et al.Pageof 9